These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Thanks, but no thanks. Underwood A Newsweek; 2007 Oct; 150(18):49. PubMed ID: 19130820 [No Abstract] [Full Text] [Related]
44. No relaxing for relators: Stringent pleading requirements result in frequent dismissal of FCA claims for off-label marketing. Clark JC; Sullivan JA Health Care Law Mon; 2009 Mar; 2009(3):2-9. PubMed ID: 19388590 [No Abstract] [Full Text] [Related]
45. Giving the industry a face. Siebert M Med Device Technol; 2001 Dec; 12(10):36-7. PubMed ID: 15966145 [No Abstract] [Full Text] [Related]
46. "Calm, but still alert": Marketing Stelazine to disturbed America, 1958-1980. Hersch MH Pharm Hist; 2008; 50(4):140-8. PubMed ID: 19831020 [No Abstract] [Full Text] [Related]
47. Reach-through claims for drug target patents: Rx for pharmaceutical policy. Bohrer RA Nat Biotechnol; 2008 Jan; 26(1):55-6. PubMed ID: 18183015 [No Abstract] [Full Text] [Related]
48. Personal effects. Can emotive marketing through relationships influence rational doctors' prescriptions? Srivastava RK Mark Health Serv; 2007; 27(4):29-32. PubMed ID: 18186452 [No Abstract] [Full Text] [Related]
49. Medical Information Systems Association. Comput Healthc; 1987 Jul; 8(8):68. PubMed ID: 10282590 [No Abstract] [Full Text] [Related]
50. Ready, aim, interview. A new study analyzes target survey audiences. Gombeski W; Wise A; Wack JT; McIntyre S; Perkins A Mark Health Serv; 2005; 25(3):41-3. PubMed ID: 16224879 [No Abstract] [Full Text] [Related]
51. Big pharma and American psychiatry. Sharfstein SS J Nerv Ment Dis; 2008 Apr; 196(4):265-6. PubMed ID: 18414119 [No Abstract] [Full Text] [Related]
53. Most drug freebies go to well-off: study. Research suggests race, gender a factor, too, but drug group calls research flawed. Rhea S Mod Healthc; 2008 Jan; 38(1):12-3. PubMed ID: 18273965 [No Abstract] [Full Text] [Related]
54. GlaxoSmithKline, Pfizer to merge HIV drug units in new company. AIDS Read; 2009; 19(6):206. PubMed ID: 19642236 [No Abstract] [Full Text] [Related]
56. Readers' and author's responses to "Physicians for sale: how medical professional organizations exploit their members". Adler AC Medscape J Med; 2008; 10(10):233; author reply 233. PubMed ID: 19117082 [No Abstract] [Full Text] [Related]
57. Readers' and author's responses to "Physicians for sale: how medical professional organizations exploit their members". Coli R Medscape J Med; 2008; 10(10):233; author reply 233. PubMed ID: 19117081 [No Abstract] [Full Text] [Related]
58. Model behavior. Gombeski WR; Medeiros C Mark Health Serv; 2004; 24(3):26-31. PubMed ID: 15453247 [No Abstract] [Full Text] [Related]